Advanced Search
Contact | Corporate | Help

Vaccine Treatment for Advanced Non-Small Cell Lung Cancer

Sponsors:
  • National Cancer Institute (NCI)
Phases:
  • Phase I
IndicationsAcronym:
  • Carcinoma, Non-Small-Cell Lung
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Hyperacute Lung Cancer Cell Vaccine
Enrollment:
54

Additional information about NCT00073398.


SourceSolution © 2008-2012